ABT (ABT) Stock Analysis

ABT (ABT) is a publicly traded company in the HEALTHCARE sector. It trades at $86.96, carries a market capitalization of $152.90B, a price-to-earnings ratio of 24.59, a dividend yield of 0.03%. This page summarizes the public market data, fundamentals, and frequently asked questions for ABT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

Market Sentiment

ABT currently has a Bullish sentiment score of 0.15.

About ABT

Abbott Laboratories (ABT) is a prominent American multinational healthcare company based in Abbott Park, Illinois, with expertise across a diverse range of sectors, including medical devices, diagnostics, nutritional products, and branded generic medicines. Established in 1888, Abbott has demonstrated a strong commitment to innovation, enhancing health outcomes through cutting-edge technology and comprehensive healthcare solutions. The company's strategic decision to spin off its research-bas...

GNG Research Analysis

GNG Research scores ABT (ABT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ABT.

Frequently Asked Questions

What is ABT's current dividend yield?

ABT (ABT) has a current dividend yield of 0.03%.

Does ABT pay dividends?

Yes, ABT pays dividends with a current yield of 0.03%.

What is ABT's P/E ratio?

ABT has a price-to-earnings (P/E) ratio of 24.59.

What is ABT's market cap?

ABT (ABT) has a market capitalization of $152.90B with a current stock price of $86.96.